Table 1.

Clinical and demographic characteristics of the 82 CN-AML patients studied

	WT1 wild type		WT1 mutant type		P value
	No.	%	No.	%
De novo	73	91.3	7	8.7
Secondary	2	100	0	0
FAB type
M1	4	100	0	0	0.344
M2	14	100	0	0
M4	27	84.4	5	15.6
M5	22	91.7	2	8.3
M6	6	100	0	0
Age
20–29	16	84.3	3	15.7	0.252
30–39	14	100	0	0
40–49	9	81.8	2	18.2
50–59	17	89.4	2	10.6
>60	19	100	0	0
Sex
Female	45	95.7	2	4.3	0.108
Male	30	85.7	5	14.3
WBC × 109/L
<10	10	100	0	0	0.434
10–49.9	34	94.5	2	5.5
50–99.9	17	85	3	15
>100	14	87.7	2	12.5
% BM blast
<30	6	100	0	0	0.038
30–49	6	100	0	0
50–79	32	82	7	18
>80	31	100	0	0
Organomegalya
Spleenomegaly	39	88.6	5	11.4	0.324
Hepatomegaly	42	87.5	6	12.5	0.127
Hemoglobin
Mean ± SD	7.78 ± 1.55		8.5 ± 0.16		0.23
Platelets
Mean ± SD	52.3 ± 40.5		43.8 ± 22.7		0.587

^aSpleenomegaly (44 patient out of 75) & hepatomegaly (48 patient out of 75)